A skin patch drug infusion device is provided. The device includes an infusion mechanism module, a control mechanism module and an adhesive patch. The infusion mechanism module includes an infusion module and a circuit module. The circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a driving unit, for pushing the driving wheel of the infusion mechanism module to implement drug infusion; a conductive tower-spring, including a middle part with a small diameter and two end parts with a large diameter in the axial direction, for fixing the driving unit and electrically connecting the driving unit and the specific connection end on the circuit board or three-dimensional circuit. The control mechanism module is electrically connected with the infusion mechanism module. The adhesive patch is used for attaching the infusion mechanism module and the control mechanism module to the skin surface.

A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an infusion module and a circuit module, the circuit module includes: a circuit board or a three-dimensional circuit coated on the surface of part components, for supplying power to specific units; a power unit, for providing power to pull the driving wheel of the infusion mechanism module to implement drug infusion; a conductive platform, provided with a conductive platform protrusion, for electrically connecting the power unit to the specific connection end on the circuit board or three-dimensional circuit; a control mechanism module, electrically connected with the infusion mechanism module; and an adhesive patch, for attaching the infusion mechanism module and the control mechanism module to the skin surface.

A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an upper case and a lower case; a control mechanism module, arranged on the lower case, and electrically connected with the infusion mechanism module; and an adhesive patch, including a tape and a protective film. The first side of the tape is fixedly connected with the lower case of the infusion mechanism module, and the second side opposite the first side of the tape is coated with a paste material, the protective film is fixed around the outer edge of the first side of the tape, the outer edge of the protective film contour corresponds to the outer edge of the tape, and the rockwell hardness of the protective film is higher than the tape.

A skin patch drug infusion device includes an infusion mechanism module, the infusion mechanism module includes an upper case and a lower case; a control mechanism module, arranged on the lower case, and electrically connected with the infusion mechanism module; and an adhesive patch, including a tape and a protective film. The first side of the tape is fixedly connected with the lower case of the infusion mechanism module, and the second side opposite the first side of the tape is coated with a paste material, the protective film is fixed around the outer edge of the first side of the tape, the outer edge of the protective film contour corresponds to the outer edge of the tape, and the rockwell hardness of the protective film is higher than the tape.

The present disclosure provides methods, systems, and devices for establishing dosing parameters for a drug administration device and establishing compatibility of components of the drug administration device. In an exemplary embodiment, a method can include acquiring data from a drug holder and communicating the data to a processor, communicating a relevant subset of dosing parameter data from a server to the processor, and establishing dosing parameters for a drug administration device based on the relevant subset of dosing parameter data. The relevant subset of dosing parameter data is determined based on the drug holder data. The method can include acquiring first component data relating to a first component of the drug administration device, comparing the first component data with acceptable first component data, and setting an operational status of the drug administration device based on the comparison.

The present disclosure provides methods, systems, and devices for establishing dosing parameters for a drug administration device and establishing compatibility of components of the drug administration device. In an exemplary embodiment, a method can include acquiring data from a drug holder and communicating the data to a processor, communicating a relevant subset of dosing parameter data from a server to the processor, and establishing dosing parameters for a drug administration device based on the relevant subset of dosing parameter data. The relevant subset of dosing parameter data is determined based on the drug holder data. The method can include acquiring first component data relating to a first component of the drug administration device, comparing the first component data with acceptable first component data, and setting an operational status of the drug administration device based on the comparison.

The present devices and method are related to treatments for obesity and for bi-directional adjustment (inflation/deflation) of intragastric balloons, thus allowing the inflation or deflation of the volume of the intragastric balloon already in a patient's stomach. A first device is configured to be introduced into the valve of the intragastric balloon and to be retained therein, and comprising a coupling element coupled to the body of the first device and configured to project outwards from the valve of the intragastric balloon. A second device comprising a tubular extension is configured to pass through the valve of the intragastric balloon, thus neutralizing its valve effect and allowing the bi-directional adjustment of same. A method is disclosed that carries out the steps of positioning an intragastric balloon already in the stomach using the first device. A shut-off valve configuration is disclosed for use with an implantable catheter.

The present devices and method are related to treatments for obesity and for bi-directional adjustment (inflation/deflation) of intragastric balloons, thus allowing the inflation or deflation of the volume of the intragastric balloon already in a patient's stomach. A first device is configured to be introduced into the valve of the intragastric balloon and to be retained therein, and comprising a coupling element coupled to the body of the first device and configured to project outwards from the valve of the intragastric balloon. A second device comprising a tubular extension is configured to pass through the valve of the intragastric balloon, thus neutralizing its valve effect and allowing the bi-directional adjustment of same. A method is disclosed that carries out the steps of positioning an intragastric balloon already in the stomach using the first device. A shut-off valve configuration is disclosed for use with an implantable catheter.

A skin patch drug infusion device, includes a control mechanism module provided with multiple first engaging portions and a first electrical connection exposed on the surface of the control mechanism module; and an infusion mechanism module including a case, with a second electrical connection exposed on the surface of the case and second engaging portions that engaged with the first engaging portions; and an alarm, non-closed arranged in the control mechanism module. When the control mechanism module and the infusion mechanism module are assembled with each other, the first engaging portions and the second engaging portions are engaged, the first electrical connection and the corresponding second electrical connection are electrically connected to each other, thereby the control mechanism module and the infusion mechanism module are electrically connected to each other.

A skin patch drug infusion device, includes a control mechanism module provided with multiple first engaging portions and a first electrical connection exposed on the surface of the control mechanism module; and an infusion mechanism module including a case, with a second electrical connection exposed on the surface of the case and second engaging portions that engaged with the first engaging portions; and an alarm, non-closed arranged in the control mechanism module. When the control mechanism module and the infusion mechanism module are assembled with each other, the first engaging portions and the second engaging portions are engaged, the first electrical connection and the corresponding second electrical connection are electrically connected to each other, thereby the control mechanism module and the infusion mechanism module are electrically connected to each other.